← Back to all trials
Not Yet Recruiting
NCT05651230
Seaweed-derived Rhamnan Sulfate and Vascular Function
Conditions: Cardiovascular Diseases
Sex: All
Ages: 35 Years – 85 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 15
Sponsor: University of Texas at Austin
Location: United States
Summary
The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.
Eligibility Criteria
Inclusion Criteria:at least one risk factor for cardiovascular disease (e.g., dyslipidemia, hypertension, obesity, impaired fasting glucose)a BMI of <40 kg/m2Exclusion Criteria:gastrointestinal disorders and/or renal diseasepregnancy or lactationstrenuous physical activity (>3 times/week)alcohol abuse
Source: ClinicalTrials.gov (NCT05651230). StuddyBuddy aggregates publicly available trial information.
